ArticlePLoS medicine2016

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Stefan Flasche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.